VANSEN PHARMA INC. — Net Income by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/2ca34a8f-0e24-45b1-adc8-dc515a18d53d/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2013 | $-268.4k | 2005-05-09 – 2013-06-30 | evidence 0001477932-13-003892 |
| FY 2012 | $-256.1k | 2005-05-09 – 2013-03-31 | evidence 0001477932-13-002256 |
| FY 2011 | $-225.1k | 2005-05-09 – 2012-03-31 | evidence 0001477932-12-001444 |
| FY 2010 | $-31.6k | 2010-01-01 – 2010-12-31 | evidence 0001477932-12-000949 |
| FY 2009 | $-27.6k | 2009-01-01 – 2009-12-31 | evidence 0001477932-12-000949 |
| FY 2008 | $-24.5k | 2008-01-01 – 2008-12-31 | evidence 0001477932-12-000949 |
| FY 2007 | $-75.2k | 2007-01-01 – 2007-12-31 | evidence 0001477932-12-000949 |
| FY 2006 | $-22.8k | 2006-01-01 – 2006-12-31 | evidence 0001477932-12-000949 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).